Intelligent Scopes Corp Unveils ISC 100 for Urology Clinics
News related to:Intelligent Scopes Corp · 2 min read
SINGAPORE and SÃO PAULO and LONDON, Oct. 18, 2026 /CourierPR/ -- Intelligent Scopes Corp has unveiled the ISC 100, a self-contained high-performance edge computing appliance designed to enhance urology clinics. The device is intended to work alongside existing cystoscopy towers, providing a seamless integration that does not require the replacement, modification, or re-validation of current equipment.
The ISC 100, which runs CystoSmart, a computer-aided detection software for white-light diagnostic cystoscopy, is a significant step for Intelligent Scopes Corp. The device is built on the NVIDIA Jetson Orin platform, ensuring that all ISC software devices, including SaMD, CADe, and CADx, run entirely on the device without a cloud connection. This feature is designed to keep patient data secure and reduce latency, making the process more efficient for healthcare providers.
According to Chetan Baxi, CEO of Intelligent Scopes Corp, the company's goal was to integrate AI technology into urology clinics without disrupting the existing workflow.
The ISC 100 offers a plug-and-play installation, requiring only two connections: the tower’s existing video output and power. It features a dual recording capability, capturing both the original endoscopy feed and the processed view, with device encryption. The integrated display is a 5.5-inch AMOLED touchscreen on a fold-flat hinge, providing a compact and portable solution for rapid deployment across different clinical settings.
Dr. Rajesh Nair, Chief Medical Officer of Intelligent Scopes Corp, emphasized the device's versatility.
The first software device on the ISC 100 is CystoSmart, which is currently cleared in Brazil (ANVISA) and Singapore (HSA). FDA De Novo, CE, UKCA, and TGA approvals are pending. The ISC 100 with CystoSmart is available for order in Brazil and Singapore. In the United States, Europe, the United Kingdom, and Australia, Intelligent Scopes Corp is accepting non-binding registrations of interest from urology departments and distribution partners. Supply will follow market authorization.
Intelligent Scopes Corp, a subsidiary of Claritas HealthTech Ltd., continues to lead global deployment of endoscopic solutions, focusing on image processing, image enhancement, AI diagnostic tools, and robotic guidance systems for endoscopy procedures. The company aims to improve detection rates, reduce unnecessary biopsies, and enhance patient outcomes through advanced technology.